H.U. Group Holdings, Inc. (TYO:4544)
Japan · Delayed Price · Currency is JPY 3,817.00
-70.00 (-1.80%)
Sep 9, 2025, 2:44 PM JST
H.U. Group Holdings Revenue
H.U. Group Holdings had revenue of 61.40B JPY in the quarter ending June 30, 2025, with 3.24% growth. This brings the company's revenue in the last twelve months to 244.95B, up 2.15% year-over-year. In the fiscal year ending March 31, 2025, H.U. Group Holdings had annual revenue of 243.03B with 2.56% growth.
Revenue (ttm)
244.95B
Revenue Growth
+2.15%
P/S Ratio
0.90
Revenue / Employee
45.00M
Employees
5,444
Market Cap
220.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 243.03B | 6.08B | 2.56% |
| Mar 31, 2024 | 236.95B | -23.96B | -9.18% |
| Mar 31, 2023 | 260.91B | -12.04B | -4.41% |
| Mar 31, 2022 | 272.94B | 49.93B | 22.39% |
| Mar 31, 2021 | 223.02B | 34.30B | 18.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |